Logo image of HGBL

HERITAGE GLOBAL INC (HGBL) Stock Fundamental Analysis

NASDAQ:HGBL - Nasdaq - US42727E1038 - Common Stock - Currency: USD

2.21  +0.03 (+1.38%)

Fundamental Rating

5

Taking everything into account, HGBL scores 5 out of 10 in our fundamental rating. HGBL was compared to 229 industry peers in the Capital Markets industry. HGBL has only an average score on both its financial health and profitability. HGBL has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

HGBL had positive earnings in the past year.
In the past year HGBL had a positive cash flow from operations.
Each year in the past 5 years HGBL has been profitable.
Of the past 5 years HGBL 4 years had a positive operating cash flow.
HGBL Yearly Net Income VS EBIT VS OCF VS FCFHGBL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M 15M

1.2 Ratios

HGBL's Return On Assets of 6.37% is fine compared to the rest of the industry. HGBL outperforms 75.11% of its industry peers.
HGBL's Return On Equity of 7.95% is in line compared to the rest of the industry. HGBL outperforms 42.79% of its industry peers.
The Return On Invested Capital of HGBL (7.02%) is better than 78.60% of its industry peers.
HGBL had an Average Return On Invested Capital over the past 3 years of 9.06%. This is in line with the industry average of 7.23%.
Industry RankSector Rank
ROA 6.37%
ROE 7.95%
ROIC 7.02%
ROA(3y)14.77%
ROA(5y)14.4%
ROE(3y)20.15%
ROE(5y)20.41%
ROIC(3y)9.06%
ROIC(5y)7.53%
HGBL Yearly ROA, ROE, ROICHGBL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

HGBL's Profit Margin of 11.42% is in line compared to the rest of the industry. HGBL outperforms 40.17% of its industry peers.
HGBL's Profit Margin has declined in the last couple of years.
HGBL has a worse Operating Margin (14.06%) than 66.81% of its industry peers.
In the last couple of years the Operating Margin of HGBL has grown nicely.
With a decent Gross Margin value of 68.86%, HGBL is doing good in the industry, outperforming 72.93% of the companies in the same industry.
HGBL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 14.06%
PM (TTM) 11.42%
GM 68.86%
OM growth 3Y13.35%
OM growth 5Y10.34%
PM growth 3Y-1.15%
PM growth 5Y-5.18%
GM growth 3Y-1.1%
GM growth 5Y-0.45%
HGBL Yearly Profit, Operating, Gross MarginsHGBL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

6

2. Health

2.1 Basic Checks

HGBL has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, HGBL has more shares outstanding
The debt/assets ratio for HGBL has been reduced compared to a year ago.
HGBL Yearly Shares OutstandingHGBL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
HGBL Yearly Total Debt VS Total AssetsHGBL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

HGBL has an Altman-Z score of 0.05. This is a bad value and indicates that HGBL is not financially healthy and even has some risk of bankruptcy.
HGBL has a worse Altman-Z score (0.05) than 76.86% of its industry peers.
HGBL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.05
Altman-Z 0.05
ROIC/WACCN/A
WACCN/A
HGBL Yearly LT Debt VS Equity VS FCFHGBL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

HGBL has a Current Ratio of 2.27. This indicates that HGBL is financially healthy and has no problem in meeting its short term obligations.
HGBL has a better Current ratio (2.27) than 75.98% of its industry peers.
A Quick Ratio of 1.90 indicates that HGBL should not have too much problems paying its short term obligations.
HGBL's Quick ratio of 1.90 is fine compared to the rest of the industry. HGBL outperforms 69.43% of its industry peers.
Industry RankSector Rank
Current Ratio 2.27
Quick Ratio 1.9
HGBL Yearly Current Assets VS Current LiabilitesHGBL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

5

3. Growth

3.1 Past

The earnings per share for HGBL have decreased strongly by -60.00% in the last year.
The Earnings Per Share has been growing slightly by 1.44% on average over the past years.
HGBL shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -25.08%.
HGBL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.63% yearly.
EPS 1Y (TTM)-60%
EPS 3Y15.87%
EPS 5Y1.44%
EPS Q2Q%-40%
Revenue 1Y (TTM)-25.08%
Revenue growth 3Y20.71%
Revenue growth 5Y11.63%
Sales Q2Q%10.68%

3.2 Future

HGBL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 30.85% yearly.
HGBL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.02% yearly.
EPS Next Y27.5%
EPS Next 2Y30.85%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.1%
Revenue Next 2Y10.02%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
HGBL Yearly Revenue VS EstimatesHGBL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
HGBL Yearly EPS VS EstimatesHGBL Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 0.1 0.2 0.3

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 18.42 indicates a rather expensive valuation of HGBL.
Compared to the rest of the industry, the Price/Earnings ratio of HGBL is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 24.95. HGBL is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 9.22, which indicates a very decent valuation of HGBL.
74.67% of the companies in the same industry are more expensive than HGBL, based on the Price/Forward Earnings ratio.
HGBL is valuated cheaply when we compare the Price/Forward Earnings ratio to 20.99, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 18.42
Fwd PE 9.22
HGBL Price Earnings VS Forward Price EarningsHGBL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20

4.2 Price Multiples

90.83% of the companies in the same industry are more expensive than HGBL, based on the Enterprise Value to EBITDA ratio.
HGBL's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. HGBL is cheaper than 74.24% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.3
EV/EBITDA 8.03
HGBL Per share dataHGBL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as HGBL's earnings are expected to grow with 30.85% in the coming years.
PEG (NY)0.67
PEG (5Y)12.83
EPS Next 2Y30.85%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for HGBL!.
Industry RankSector Rank
Dividend Yield N/A

HERITAGE GLOBAL INC

NASDAQ:HGBL (5/13/2025, 8:00:01 PM)

2.21

+0.03 (+1.38%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)08-06 2025-08-06/amc
Inst Owners36.32%
Inst Owner Change-1.71%
Ins Owners11.91%
Ins Owner Change-0.05%
Market Cap78.34M
Analysts84
Price Target3.75 (69.68%)
Short Float %0.04%
Short Ratio0.21
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-85.99%
Min EPS beat(2)-121.01%
Max EPS beat(2)-50.98%
EPS beat(4)0
Avg EPS beat(4)-49.14%
Min EPS beat(4)-121.01%
Max EPS beat(4)-1.96%
EPS beat(8)3
Avg EPS beat(8)-9.44%
EPS beat(12)6
Avg EPS beat(12)7.6%
EPS beat(16)6
Avg EPS beat(16)-6.67%
Revenue beat(2)0
Avg Revenue beat(2)-18.92%
Min Revenue beat(2)-23.68%
Max Revenue beat(2)-14.15%
Revenue beat(4)0
Avg Revenue beat(4)-17.64%
Min Revenue beat(4)-23.68%
Max Revenue beat(4)-14.15%
Revenue beat(8)2
Avg Revenue beat(8)-4.98%
Revenue beat(12)6
Avg Revenue beat(12)4.44%
Revenue beat(16)8
Avg Revenue beat(16)1.2%
PT rev (1m)-4.13%
PT rev (3m)-11.8%
EPS NQ rev (1m)2.26%
EPS NQ rev (3m)-29.68%
EPS NY rev (1m)-2.78%
EPS NY rev (3m)-25%
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)-7.94%
Revenue NY rev (1m)-0.59%
Revenue NY rev (3m)-12.03%
Valuation
Industry RankSector Rank
PE 18.42
Fwd PE 9.22
P/S 1.73
P/FCF 10.3
P/OCF 10.12
P/B 1.2
P/tB 1.44
EV/EBITDA 8.03
EPS(TTM)0.12
EY5.43%
EPS(NY)0.24
Fwd EY10.85%
FCF(TTM)0.21
FCFY9.71%
OCF(TTM)0.22
OCFY9.89%
SpS1.28
BVpS1.84
TBVpS1.53
PEG (NY)0.67
PEG (5Y)12.83
Profitability
Industry RankSector Rank
ROA 6.37%
ROE 7.95%
ROCE 9.56%
ROIC 7.02%
ROICexc 10.42%
ROICexgc 13.72%
OM 14.06%
PM (TTM) 11.42%
GM 68.86%
FCFM 16.77%
ROA(3y)14.77%
ROA(5y)14.4%
ROE(3y)20.15%
ROE(5y)20.41%
ROIC(3y)9.06%
ROIC(5y)7.53%
ROICexc(3y)11.88%
ROICexc(5y)13.37%
ROICexgc(3y)15.54%
ROICexgc(5y)N/A
ROCE(3y)12.33%
ROCE(5y)10.25%
ROICexcg growth 3Y-7.36%
ROICexcg growth 5Y-37.82%
ROICexc growth 3Y8.82%
ROICexc growth 5Y-8.63%
OM growth 3Y13.35%
OM growth 5Y10.34%
PM growth 3Y-1.15%
PM growth 5Y-5.18%
GM growth 3Y-1.1%
GM growth 5Y-0.45%
F-Score7
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.05
Debt/EBITDA 0
Cap/Depr 23.18%
Cap/Sales 0.3%
Interest Coverage 70.09
Cash Conversion 111.14%
Profit Quality 146.82%
Current Ratio 2.27
Quick Ratio 1.9
Altman-Z 0.05
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)37.97%
Cap/Depr(5y)85.51%
Cap/Sales(3y)0.4%
Cap/Sales(5y)1.36%
Profit Quality(3y)96.52%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-60%
EPS 3Y15.87%
EPS 5Y1.44%
EPS Q2Q%-40%
EPS Next Y27.5%
EPS Next 2Y30.85%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-25.08%
Revenue growth 3Y20.71%
Revenue growth 5Y11.63%
Sales Q2Q%10.68%
Revenue Next Year5.1%
Revenue Next 2Y10.02%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-51.87%
EBIT growth 3Y36.82%
EBIT growth 5Y23.17%
EBIT Next Year7.9%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-40.39%
FCF growth 3YN/A
FCF growth 5Y62.57%
OCF growth 1Y-40.52%
OCF growth 3YN/A
OCF growth 5Y57.86%